
<DOC>
<DOCNO>
WSJ900905-0071
</DOCNO>
<DOCID>
900905-0071.
</DOCID>
<HL>
   Who's News:
   Schering, SmithKline
   Name U.S. Executives
   ----
   A Wall Street Journal News Roundup
</HL>
<DATE>
09/05/90
</DATE>
<SO>
WALL STREET JOURNAL (J), PAGE B12
</SO>
<CO>
   SGP SBE WNEWS
</CO>
<IN>
DRUG MANUFACTURERS (DRG)
</IN>
<LP>
   Two big pharmaceutical companies named executives to head
their respective U.S. businesses.
   Schering-Plough Corp., Madison, N.J., said Rodolfo C.
Bryce was appointed president of Schering Laboratories, the
company's U.S. prescription-products unit. Mr. Bryce, 44
years old, previously was senior vice president, prescription
marketing and sales, at Schering Labs.
</LP>
<TEXT>
   Mr. Bryce succeeds Jean-Pierre Garnier, 43, who was named
president of the U.S. pharmaceuticals business of SmithKline
Beecham PLC, London, succeeding Frederick Kyle, who was named
president, commercial operations, of the Anglo-American drug
concern's world-wide operations earlier this year.
</TEXT>
</DOC>